[A clinical study on anti-inflammatory effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005128:Eye Diseases / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D011743:Pyrimidines